Cue Biopharma Inc (CUE)
1.70
-0.04
(-2.30%)
USD |
NASDAQ |
May 17, 16:00
1.70
0.00 (0.00%)
After-Hours: 20:00
Cue Biopharma Enterprise Value: 49.36M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 49.36M |
| May 16, 2024 | 50.82M |
| May 15, 2024 | 45.95M |
| May 14, 2024 | 41.58M |
| May 13, 2024 | 46.44M |
| May 10, 2024 | 50.82M |
| May 09, 2024 | 59.33M |
| May 08, 2024 | 59.09M |
| May 07, 2024 | 72.22M |
| May 06, 2024 | 67.36M |
| May 03, 2024 | 69.79M |
| May 02, 2024 | 57.63M |
| May 01, 2024 | 58.84M |
| April 30, 2024 | 58.60M |
| April 29, 2024 | 35.25M |
| April 26, 2024 | 32.58M |
| April 25, 2024 | 34.77M |
| April 24, 2024 | 35.25M |
| April 23, 2024 | 39.14M |
| April 22, 2024 | 42.55M |
| April 19, 2024 | 42.06M |
| April 18, 2024 | 43.03M |
| April 17, 2024 | 45.47M |
| April 16, 2024 | 38.90M |
| April 15, 2024 | 43.76M |
| Date | Value |
|---|---|
| April 12, 2024 | 51.30M |
| April 11, 2024 | 51.79M |
| April 10, 2024 | 52.52M |
| April 09, 2024 | 58.60M |
| April 08, 2024 | 65.41M |
| April 05, 2024 | 56.17M |
| April 04, 2024 | 52.76M |
| April 03, 2024 | 52.28M |
| April 02, 2024 | 54.71M |
| April 01, 2024 | 58.60M |
| March 31, 2024 | 58.11M |
| March 28, 2024 | 51.59M |
| March 27, 2024 | 49.15M |
| March 26, 2024 | 49.15M |
| March 25, 2024 | 50.13M |
| March 22, 2024 | 49.36M |
| March 21, 2024 | 51.25M |
| March 20, 2024 | 53.14M |
| March 19, 2024 | 48.42M |
| March 18, 2024 | 53.61M |
| March 15, 2024 | 57.39M |
| March 14, 2024 | 55.50M |
| March 13, 2024 | 61.16M |
| March 12, 2024 | 43.22M |
| March 11, 2024 | 49.36M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
25.87M
Minimum
Sep 27 2022
825.53M
Maximum
Jun 02 2020
215.29M
Average
147.97M
Median
Enterprise Value Benchmarks
| Precision BioSciences Inc | -29.43M |
| NovaBay Pharmaceuticals Inc | 5.156M |
| Palatin Technologies Inc | 22.26M |
| iBio Inc | 16.77M |
| Theriva Biologics Inc | -8.901M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.35M |
| Revenue (Quarterly) | 1.717M |
| Total Expenses (Quarterly) | 14.38M |
| EPS Diluted (Quarterly) | -0.25 |
| Profit Margin (Quarterly) | -719.1% |
| Earnings Yield | -62.57% |
| Normalized Earnings Yield | -62.38 |